Prostate cancer
RecruitingStudy on the Use of [18F]PSMA-1007 PET/CT Imaging for Detecting Prostate Cancer in Patients with Newly Diagnosed High-Risk or Very-High-Risk Conditions
Study on the Use of [18F]PSMA-1007 PET/CT Imaging for Detecting Prostate Cancer in Patients with Newly Diagnosed High-Risk or Very-High-Risk Conditions
- Disease:Prostate cancer
- Substances:18F-Psma-1007
France- Participants:18–64 years · 65+ years
- Substances:18F-Psma-1007
- Sponsor:Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH



